Synthetic ACTH(4–7)-derived heptapeptide analogue
PRODUCT PROFILE
Semax
Price range: £24.99 through £42.99
Semax is synthetic acth(4–7)-derived heptapeptide analogue. Researchers examine it in relation to neuroprotection, cerebral-ischaemia models and neurotrophic signalling.
Why it is distinct
ACTH-fragment lineage and neuroprotection focus distinguish it from Selank’s tuftsin/anxiety profile.
- Evidence stageEarly human evidence
- AvailabilityAvailable · 20 in stock
- Batch recordPublished after verification
- DispatchConfirmed at checkout
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
Semax is synthetic acth(4–7)-derived heptapeptide analogue. Researchers examine it in relation to neuroprotection, cerebral-ischaemia models and neurotrophic signalling.
Research focus+
Researchers study whether it can protect nerve cells and influence learning, memory and recovery after reduced blood flow to the brain. Evidence is limited and varies by country and formulation.
How the mechanism differs+
Reported to influence BDNF-related, melanocortin-adjacent and oxidative-stress pathways without corticosteroid activity.
Evidence and limitations+
Regional clinical use and small studies exist, but evidence is not established to major international authorisation standards.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Researchers study whether it can protect nerve cells and influence learning, memory and recovery after reduced blood flow to the brain. Evidence is limited and varies by country and formulation.
Reported to influence BDNF-related, melanocortin-adjacent and oxidative-stress pathways without corticosteroid activity.
ACTH-fragment lineage and neuroprotection focus distinguish it from Selank’s tuftsin/anxiety profile.
Regional clinical use and small studies exist, but evidence is not established to major international authorisation standards.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Experimental
Dihexa
£66.0010 mgBatch file pendingHGF/c-Met synaptogenesis hypothesis, unlike Semax’s neurotrophic ACTH-fragment lineage.
UnavailableAsk about availability -
Early human evidence
DSIP
£13.995 mgBatch file pendingSleep is its historical research label, but mechanistic certainty is much lower than for receptor-defined peptides.
UnavailableAsk about availability -
Experimental
Pinealon
£46.0020 mgBatch file pendingA tissue-bioregulator concept with uncertain targets, unlike receptor-defined Semax or Selank research.
UnavailableAsk about availability -
Experimental
P21
£58.0010 mgBatch file pendingA CNTF-lineage neurotrophic research material whose exact sequence must be verified before meaningful comparison.
UnavailableAsk about availability